Candriam S.C.A. - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 68 filers reported holding REDHILL BIOPHARMA LTD in Q4 2020. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q1 2022$180,000
-2.2%
71,2670.0%0.00%0.0%
Q4 2021$184,000
-51.3%
71,267
-13.6%
0.00%
-66.7%
Q3 2021$378,000
-33.5%
82,5230.0%0.00%
-25.0%
Q2 2021$568,000
-10.8%
82,5230.0%0.00%
-20.0%
Q1 2021$637,000
-3.9%
82,5230.0%0.01%0.0%
Q4 2020$663,000
-21.4%
82,5230.0%0.01%
-37.5%
Q3 2020$843,000
+52.4%
82,5230.0%0.01%
+33.3%
Q2 2020$553,000
+30.4%
82,523
+15.8%
0.01%
+20.0%
Q1 2020$424,000
-2.1%
71,2670.0%0.01%0.0%
Q4 2019$433,000
-13.7%
71,2670.0%0.01%
-28.6%
Q3 2019$502,000
+8.9%
71,2670.0%0.01%
+16.7%
Q2 2019$461,000
-22.1%
71,2670.0%0.01%
-25.0%
Q1 2019$592,000
+49.9%
71,2670.0%0.01%
+33.3%
Q4 2018$395,000
-37.2%
71,2670.0%0.01%
-25.0%
Q3 2018$629,000
+3.5%
71,2670.0%0.01%
-20.0%
Q2 2018$608,000
+65.7%
71,2670.0%0.01%
+66.7%
Q1 2018$367,000
-0.3%
71,2670.0%0.01%0.0%
Q4 2017$368,000
-52.2%
71,2670.0%0.01%
-53.8%
Q3 2017$770,000
+24.4%
71,2670.0%0.01%
+8.3%
Q2 2017$619,000
-9.4%
71,2670.0%0.01%
-7.7%
Q1 2017$683,000
-8.3%
71,2670.0%0.01%
-23.5%
Q4 2016$745,000
-24.9%
71,2670.0%0.02%
-29.2%
Q3 2016$992,000
+27.5%
71,2670.0%0.02%
+20.0%
Q2 2016$778,000
-10.4%
71,2670.0%0.02%
-9.1%
Q1 2016$868,000
-5.0%
71,2670.0%0.02%
-8.3%
Q4 2015$914,000
-0.7%
71,2670.0%0.02%
+4.3%
Q3 2015$920,000
-26.7%
71,2670.0%0.02%
-11.5%
Q2 2015$1,255,000
+21.1%
71,2670.0%0.03%
+23.8%
Q1 2015$1,036,000
+9.6%
71,2670.0%0.02%
+5.0%
Q4 2014$945,00071,2670.02%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q4 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 300$2,1750.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REDHILL BIOPHARMA LTD shareholders